[[8, 42, [[2, 798, "Table 2. Discovery of the N-Benzyl Piperidine Scaffold"]]], [70, 91, [[926, 936, "0"], [969, 988, "0"]]], [120, 149, [[1019, 1068, "CH3"]]], [317, 384, [[241, 275, "Ex"], [418, 445, "R"], [553, 669, "Na1.7 K; (nM)a"], [685, 1027, "Na1.7 Na1.5 b FIux (nM) /FoIdb Flux (nM)b"], [1059, 1199, "Na,1.7 Flux PS (fold)c"], [1233, 1390, "HLM /HH (m/min/kg)d"], [1399, 1576, "LogD7.4/LLEe"]]], [479, 513, [[245, 267, "3"], [590, 631, "1.6"], [732, 769, "25"], [866, 988, "1100 / 44x"], [1100, 1156, "1.2x"], [1270, 1348, "19 /17"], [1438, 1537, "3.3 / 5.5"]]], [623, 660, [[250, 267, "9"], [349, 368, "Pr"], [590, 633, "5.5"], [732, 769, "23"], [864, 990, "1100 / 48x"], [1102, 1158, "8.3x"], [1266, 1354, "6.7 /15"], [1440, 1537, "1.8 /6.4"]]], [686, 709, [[396, 430, "Ph"]]], [777, 808, [[243, 275, "10"], [338, 360, "Pr"], [590, 633, "3.6"], [732, 769, "66"], [872, 984, "590 / 8.9x"], [1102, 1158, "0.6x"], [1257, 1365, "5.5 / <6.2"], [1442, 1535, "2.7 / 5.7"]]], [840, 863, [[388, 420, "Ph"]]], [925, 958, [[243, 271, "11"], [581, 641, "1800"], [713, 788, "25000"], [842, 1012, ">30000 />1.2x"], [1100, 1156, "1.0x"], [1257, 1356, "ND /ND"], [1438, 1537, "0.1 / 5.6"]]], [1053, 1081, [[243, 273, "12"], [586, 635, "140"], [719, 783, "3200"], [842, 1014, ">30000 / >9.1x"], [1100, 1156, "1.4x"], [1266, 1354, "4.8 /15"], [1440, 1535, "0.3 / 6.7"]]], [1157, 1233, [[0, 1791, "ahNa,1.7 K; from a radioligand binding assay. b1Cso of sodium influx in cells transfected with hNav1.7 or hNav1.5. 1Cso of sodium influx in the. presence of 3 mg/mL BSA. dScaled hepatic clearance from human liver microsomes and hepatocytes. LLE was calculated using Na,1.7 K and"]]], [1235, 1267, [[4, 407, "LogD74 (LLE = pK - LogD7.4)"]]]]